BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 15887862)

  • 21. Postoperative growth hormone dynamics in clinically nonfunctioning pituitary adenoma.
    Kobayashi N; Yamaguchi-Okada M; Horiguchi K; Fukuhara N; Nishioka H; Yamada S
    Endocr J; 2018 Aug; 65(8):827-832. PubMed ID: 29910227
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Usefulness of IGF-I assay for the diagnosis of GH deficiency in adults.
    Aimaretti G; Corneli G; Razzore P; Bellone S; Baffoni C; Bellone J; Camanni F; Ghigo E
    J Endocrinol Invest; 1998 Sep; 21(8):506-11. PubMed ID: 9801991
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preoperative growth hormone (GH) peak values during a GH releasing peptide-2 test reflect the severity of hypopituitarism and the postoperative recovery of GH secretion in patients with non-functioning pituitary adenomas.
    Soga A; Fukuda I; Kobayashi S; Tahara S; Morita A; Sugihara H
    Endocr J; 2020 Feb; 67(2):167-175. PubMed ID: 31776295
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of GH and/or testosterone deficiency on the prostate: an ultrasonographic and endocrine study in GH-deficient adult patients.
    Colao A; Spiezia S; Di Somma C; Marzullo P; Cerbone G; Pivonello R; Faggiano A; Lombardi G
    Eur J Endocrinol; 2000 Jul; 143(1):61-9. PubMed ID: 10870032
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnosis of growth hormone deficiency after pituitary surgery: the combined acipimox/GH-releasing hormone test.
    van Dam PS; Dieguez C; Cordido F; de Vries WR; Veldhuyzen BF; van Thiel E; Casanueva FF; Koppeschaar HP
    Clin Endocrinol (Oxf); 2003 Feb; 58(2):156-62. PubMed ID: 12580930
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elderly people with hypothalamic-pituitary disease and growth hormone deficiency: lipid profiles, body composition and quality of life compared with control subjects.
    Li Voon Chong JS; Benbow S; Foy P; Wallymahmed ME; Wile D; MacFarlane IA
    Clin Endocrinol (Oxf); 2000 Nov; 53(5):551-9. PubMed ID: 11106915
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.
    Mukherjee A; Murray RD; Teasdale GM; Shalet SM
    Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Growth hormone (GH) responses to GH-releasing hormone alone or combined with arginine in patients with adrenal incidentaloma: evidence for enhanced somatostatinergic tone.
    Terzolo M; Bossoni S; Alí A; Doga M; Reimondo G; Milani G; Peretti P; Manelli F; Angeli A; Giustina A
    J Clin Endocrinol Metab; 2000 Mar; 85(3):1310-5. PubMed ID: 10720081
    [TBL] [Abstract][Full Text] [Related]  

  • 29. GH deficiency in patients irradiated for acromegaly: significance of GH stimulatory tests in relation to the 24 h GH secretion.
    van der Klaauw AA; Pereira AM; van Thiel SW; Smit JW; Corssmit EP; Biermasz NR; Frolich M; Iranmanesh A; Veldhuis JD; Roelfsema F; Romijn JA
    Eur J Endocrinol; 2006 Jun; 154(6):851-8. PubMed ID: 16728545
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sensitivity and specificity of six tests for the diagnosis of adult GH deficiency.
    Biller BM; Samuels MH; Zagar A; Cook DM; Arafah BM; Bonert V; Stavrou S; Kleinberg DL; Chipman JJ; Hartman ML
    J Clin Endocrinol Metab; 2002 May; 87(5):2067-79. PubMed ID: 11994342
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low dose hexarelin and growth hormone (GH)-releasing hormone as a diagnostic tool for the diagnosis of GH deficiency in adults: comparison with insulin-induced hypoglycemia test.
    Gasperi M; Aimaretti G; Scarcello G; Corneli G; Cosci C; Arvat E; Martino E; Ghigo E
    J Clin Endocrinol Metab; 1999 Aug; 84(8):2633-7. PubMed ID: 10443652
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endocrine responses to ghrelin in adult patients with isolated childhood-onset growth hormone deficiency.
    Aimaretti G; Baffoni C; Broglio F; Janssen JA; Corneli G; Deghenghi R; van der Lely AJ; Ghigo E; Arvat E
    Clin Endocrinol (Oxf); 2002 Jun; 56(6):765-71. PubMed ID: 12072046
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum levels of insulin-like growth factor I in 152 patients with growth hormone deficiency, aged 19-82 years, in relation to those in healthy subjects.
    Hilding A; Hall K; Wivall-Helleryd IL; Sääf M; Melin AL; Thorén M
    J Clin Endocrinol Metab; 1999 Jun; 84(6):2013-9. PubMed ID: 10372703
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The natural history of partial growth hormone deficiency in adults: a prospective study on the cardiovascular risk and atherosclerosis.
    Colao A; Di Somma C; Spiezia S; Rota F; Pivonello R; Savastano S; Lombardi G
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2191-200. PubMed ID: 16537686
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Do all patients with childhood-onset growth hormone deficiency (GHD) and ectopic neurohypophysis have persistent GHD in adulthood?
    Léger J; Danner S; Simon D; Garel C; Czernichow P
    J Clin Endocrinol Metab; 2005 Feb; 90(2):650-6. PubMed ID: 15546901
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Administration of arginine plus growth hormone releasing hormone to evaluate growth hormone (GH) secretory status in children with GH deficiency.
    Keller A; Donaubauer J; Kratzsch J; Pfaeffle R; Hirsch W; Kiess W; Keller E
    J Pediatr Endocrinol Metab; 2007 Dec; 20(12):1307-14. PubMed ID: 18341090
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of GH/IGF-I axis in obesity by evaluation of IGF-I levels and the GH response to GHRH+arginine test.
    Maccario M; Gauna C; Procopio M; Di Vito L; Rossetto R; Oleandri SE; Grottoli S; Ganzaroli C; Aimaretti G; Ghigo E
    J Endocrinol Invest; 1999 Jun; 22(6):424-9. PubMed ID: 10435851
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Growth hormone deficiency in elderly patients with hypothalamo-pituitary tumors.
    Colao A; Cerbone G; Pivonello R; Klain M; Aimaretti G; Faggiano A; Di Somma C; Salvatore M; Lombardi G
    Pituitary; 1998 Apr; 1(1):59-67. PubMed ID: 11081184
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The usefulness of the combined growth hormone (GH)-releasing hormone and arginine stimulation test in the diagnosis of radiation-induced GH deficiency is dependent on the post-irradiation time interval.
    Darzy KH; Aimaretti G; Wieringa G; Gattamaneni HR; Ghigo E; Shalet SM
    J Clin Endocrinol Metab; 2003 Jan; 88(1):95-102. PubMed ID: 12519836
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The hypothalamus-pituitary function after pituitary stereotactic radiosurgery: evaluation of growth hormone deficiency.
    Degerblad M; Brismar K; Rähn T; Thorén M
    J Intern Med; 2003 Apr; 253(4):454-62. PubMed ID: 12653875
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.